SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001493152-23-018590
Filing Date
2023-05-22
Accepted
2023-05-22 17:22:53
Documents
96
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 form10-k.htm   iXBRL 10-K 3414448
2 ex21-1.htm EX-21.1 3640
3 ex23-1.htm EX-23.1 3495
4 ex23-2.htm EX-23.2 3697
5 ex31-1.htm EX-31.1 13277
6 ex31-2.htm EX-31.2 13271
7 ex32-1.htm EX-32.1 6995
8 ex32-2.htm EX-32.2 7154
9 form10-k_001.jpg GRAPHIC 56001
10 form10-k_002.jpg GRAPHIC 46493
11 form10-k_003.jpg GRAPHIC 54918
12 form10-k_004.jpg GRAPHIC 115513
13 form10-k_005.jpg GRAPHIC 72091
14 form10-k_006.jpg GRAPHIC 80303
  Complete submission text file 0001493152-23-018590.txt   13753229

Data Files

Seq Description Document Type Size
15 XBRL SCHEMA FILE ards-20221231.xsd EX-101.SCH 79294
16 XBRL CALCULATION FILE ards-20221231_cal.xml EX-101.CAL 75728
17 XBRL DEFINITION FILE ards-20221231_def.xml EX-101.DEF 378864
18 XBRL LABEL FILE ards-20221231_lab.xml EX-101.LAB 583109
19 XBRL PRESENTATION FILE ards-20221231_pre.xml EX-101.PRE 489970
90 EXTRACTED XBRL INSTANCE DOCUMENT form10-k_htm.xml XML 2222658
Mailing Address 983 UNIVERSITY AVENUE, BLDG. B LOS GATOS CA 95032
Business Address 983 UNIVERSITY AVENUE, BLDG. B LOS GATOS CA 95032 (408) 385-1742
Aridis Pharmaceuticals, Inc. (Filer) CIK: 0001614067 (see all company filings)

IRS No.: 320074500 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-38630 | Film No.: 23945703
SIC: 2834 Pharmaceutical Preparations